攝護腺症狀評分工具
Prostate Symptom Assessment · IPSS & NIH-CPSI
IPSS 國際攝護腺症狀評分表
International Prostate Symptom Score · Barry 1992 · 7 題症狀 + 1 題生活品質(Q8 不計入總分)
IPSS—/ 350/7 題
過去一個月,您是否有排尿後仍有膀胱未排空感覺?Incomplete emptying: Over the past month, how often have you had the sensation of not emptying your bladder completely after urinating?
—過去一個月,您是否在排尿後 2 小時內又需再次排尿?Frequency: Over the past month, how often have you had to urinate again less than two hours after you finished urinating?
—過去一個月,您是否有排尿時,尿流斷斷續續的情形?Intermittency: Over the past month, how often have you found you stopped and started again several times when urinating?
—過去一個月,您是否有難以延遲排尿的情形?Urgency: Over the past month, how difficult have you found it to postpone urination?
—過去一個月,您是否有排尿時尿流無力的情形?Weak stream: Over the past month, how often have you had a weak urinary stream?
—過去一個月,您是否有需要用力才能開始排尿的情形?Straining: Over the past month, how often have you had to push or strain to begin urination?
—過去一個月,您夜間從睡覺到早上起床,通常需要起床排尿幾次?Nocturia: Over the past month, how many times did you most typically get up to urinate from the time you went to bed until the time you got up in the morning?
—如果您必須在餘生中,都保持現在的泌尿狀況,您的感受如何?If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that?
——/ 35
IPSS填寫中
IPSS 為症狀評估工具,不能取代泌尿科完整評估,亦不能診斷 BPH。Q8 生活品質評分是治療決策的重要依據,即使 IPSS 分數偏低,若 Q8 ≥ 4 仍建議積極介入。IPSS 與尿流速、殘尿量及攝護腺體積相關性有限。
已完成 0/7 題,尚餘 7 題
IPSS 國際攝護腺症狀評分
International Prostate Symptom Score(IPSS) 為 7 題排尿症狀量表(各 0–5 分,總分 0–35)加 1 題生活品質評估(0–6,不計入總分),用於評估良性攝護腺肥大(BPH)下尿路症狀嚴重度。
| 項目 | 分類 |
|---|---|
| 排空不全感、頻尿、間歇、急迫、滴尿感 | 儲尿 / 排尿症狀 |
| 尿流細弱、需用力 | 排尿症狀 |
| 夜尿 | 儲尿症狀(0–5 對應次數) |
分數意義與處置
| 總分 | 嚴重度 | 意義與建議處置 |
|---|---|---|
| 0–7 | 輕度 | 症狀輕微,觀察追蹤、生活型態調整 |
| 8–19 | 中度 | 建議藥物治療(α 阻斷劑、5-ARI),追蹤反應 |
| 20–35 | 重度 | 症狀顯著,評估藥物或手術(TURP 等) |
IPSS 主要反映症狀負擔,與攝護腺體積、尿流速並非完全相關。第 8 題「生活品質」(0–6)是重要的治療決策依據——即使總分中度,若病人對症狀高度困擾(QoL ≥ 4),也應積極治療。IPSS 常用於追蹤治療前後的症狀變化。
NIH-CPSI 慢性攝護腺炎症狀評分
NIH Chronic Prostatitis Symptom Index(NIH-CPSI) 為 9 題量表,分三個面向評估慢性攝護腺炎 / 慢性骨盆疼痛症候群(CP/CPPS):
| 面向 | 題目 | 分數範圍 |
|---|---|---|
| 疼痛(Pain) | Q1–Q4 | 0–21 |
| 排尿(Urinary) | Q5–Q6 | 0–10 |
| 生活品質(QoL) | Q7–Q9 | 0–12 |
分數意義與處置
| 疼痛分數 | 嚴重度 | 意義 |
|---|---|---|
| 0–7 | 輕度 | 疼痛負擔輕微 |
| 8–14 | 中度 | 疼痛明顯,影響生活 |
| 15–21 | 重度 | 疼痛嚴重,需積極多模式治療 |
NIH-CPSI 的疼痛面向(Q1–Q4)最具鑑別力,其中 Q4 為 0–10 疼痛強度評分。總分(0–43)用於追蹤治療反應:分數下降 ≥ 6 分通常視為有臨床意義的改善。CP/CPPS 治療常採 UPOINT 表型導向的多模式策略;症狀量表不能取代排除感染、癌症等其他病因的評估。
注意事項
症狀量表非診斷
IPSS 與 NIH-CPSI 量化症狀嚴重度與生活品質影響,不能單獨作為診斷;需結合病史、理學檢查與必要檢驗。
免責聲明
本工具僅供臨床輔助與教學參考,最終診斷與治療應由醫師依完整評估判定。
參考文獻
- Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148(5):1549–1557.
- Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). J Urol. 1999;162(2):369–375.